The CD4+ regulatory T-cells is decreased in adults with latent autoimmune diabetes

被引:33
|
作者
Yang, Zhifang [1 ]
Zhou, Zhiguang [1 ]
Huang, Gan [1 ]
Ling, He [1 ]
Yan, Xiang [1 ]
Peng, Jian [1 ]
Li, Xia [1 ]
机构
[1] Cent S Univ, Inst Metab & Endocrinol, Xiangya Hosp 2, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
the latent autoimmune diabetes in adults; CD4(+)CD25(+); FOXP3;
D O I
10.1016/j.diabres.2006.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The latent autoimmune diabetes in adults (LADA) is a subgroup of type I diabetes, which procession of autoimmune destruction of beta-cells was slower than classic type I diabetes. To investigate the pathogenesis of LADA, we examined the lymphocyte subsets including the CD4(+)CD25(+) T-cells in 60 LADA patients and M patients of type 2 diabetes and 30 healthy individuals by FACS. And we compared the expression of FOXP3 mRNA in CD4(+) T-cell between 10 patients of LADA and 10 matched healthy individuals by real time PCR. The percent of CD4(+)CD25(+) T-cells were higher (11.89 +/- 4.96% versus 8.16 +/- 3.65%, P < 0.01), and the percent CD8(+) T-cells elevated (24.58 +/- 6.80% versus 19.39 +/- 7.12, P < 0.01) in LADA patients than healthy individuals. While the expression of FOXP3 mRNA in CD4(+) T-cell was markedly decreased in LADA patients (0.52-fold, n = 10, P = 0.004) compared with normal subjects. In addition, the percent of CD8(+) T-cells related with GAD-Ab titers in LADA patients (r = 0.292, P = 0.03). Our results showed that there were cellular immune disorder and decreased CD4(+) regulatory T-cells in LADA patients. The adoptive transfer regulatory T-cells seem to be a potential therapeutics for LADA. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 50 条
  • [21] Where CD4+ CD25+ T reg cells impinge on autoimmune diabetes
    Chen, ZB
    Herman, AE
    Matos, M
    Mathis, D
    Benoist, C
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (10): : 1387 - 1397
  • [22] Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes
    Kakabadse, Dimitri
    Chen, Dawei
    Fishman, Sigal
    Weinstein-Marom, Hadas
    Davies, Joanne
    Wen, Li
    Gross, Gideon
    Wong, F. Susan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Decreased effector regulatory T cells and increased activated CD4+ T cells in premature ovarian insufficiency
    Kobayashi, Mutsumi
    Nakashima, Akitoshi
    Yoshino, Osamu
    Yoshie, Masanori
    Ushijima, Akemi
    Ito, Masami
    Ono, Yosuke
    Shima, Tomoko
    Kawamura, Kazuhiro
    Ishizuka, Bunpei
    Saito, Shigeru
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2019, 81 (06)
  • [24] EVIDENCE OF CD4+ REGULATORY T-CELLS IN THE NONOBESE DIABETIC MALE-MOUSE
    SEMPE, P
    RICHARD, MF
    BACH, JF
    BOITARD, C
    DIABETOLOGIA, 1994, 37 (04) : 337 - 343
  • [25] Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer
    Wang, RF
    SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) : 73 - 79
  • [26] CD4+ CD25+ regulatory T cells control induction of autoimmune hemolytic anemia
    Mqadmi, A
    Zheng, XY
    Yazdanbakhsh, K
    BLOOD, 2005, 105 (09) : 3746 - 3748
  • [27] Aged regulatory T cells fail to control autoimmune lacrimal gland pathogenic CD4+ T cells
    Scholand, Kaitlin K.
    Schaefer, Laura
    Govindarajan, Gowthaman
    Yu, Zhiyuan
    Galletti, Jeremias G.
    de Paiva, Cintia S.
    GEROSCIENCE, 2025,
  • [28] CD4+ CD25+ FoxP3+ regulatory T cells in autoimmune diseases
    Valencia, Xavier
    Lipsky, Peter E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (11): : 619 - 626
  • [29] Reduction of CD4+CD25+ regulatory T-cells in migraine: Is migraine an autoimmune disorder?
    Arumugam, Murugesan
    Parthasarathy, Varadarajan
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 290 : 54 - 59
  • [30] CD4+CD25high regulatory T cells in human autoimmune diabetes
    Putnam, AL
    Vendrame, F
    Dotta, F
    Gottlieb, PA
    JOURNAL OF AUTOIMMUNITY, 2005, 24 (01) : 55 - 62